Algorithm Helps DETECT Pulmonary Hypertension in Systemic Sclerosis

admin avatar

by admin |

Share this article:

Share article via email

According to the University of Michigan’s Department of Internal Medicine Patients, “Patients with limited scleroderma have the risk of developing progressive blood vessel narrowing in the lungs frequently in the absence of lung scarring and inflammation. This complication is called pulmonary arterial hypertension (PAH).”

Learn more about this relation here.

In this ElsGlobalMedicalNews video, watch Dr. Dinesh Khanna talk about how the use of a two-step algorithm significantly increased the rate of pulmonary arterial hypertension (PAH) diagnosis in systemic sclerosis patients.

Last year, a review study suggested that borderline pulmonary pressure in patients with scleroderma can represent a condition of pre-pulmonary arterial hypertension (PAH). 

Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.